Myriad Genetics Inc
MYGN
$4.15-1.31%
Delayed · as of Oct 13, 2026, 11:45 AM ET
Mkt cap
$413.68M
EV/Sales
0.47
P/E ratio
N/A
FY2025 Revenue
$824.50M
EPS (TTM)
$-1.18
Gross Margin (FY2025)
69.93%
Profit Margin (FY2025)
-44.38%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Myriad Genetics Inc (MYGN) is a diagnostics & research company listed on NASDAQ.
Latest reported MYGN revenue for 2025-12-31 was $824.5M. Net income was -$365.9M. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. MYGN currently screens at market cap $413.7M.
Use this MYGN research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full MYGN income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Myriad Genetics Inc (MYGN) is a diagnostics & research company in the Healthcare sector.
Latest cached Myriad Genetics Inc (MYGN) revenue for Dec 31, 2025 was $824.5M. Net income was -$365.9M. Statements: https://lician.com/financials/mygn
Myriad Genetics Inc (MYGN) market capitalization is $413.7M on the latest cached snapshot.
Myriad Genetics Inc (MYGN) cached previous close $4.20; day range $4.13 – $4.20; volume 324,508. Session quote: https://lician.com/quote/mygn
Myriad Genetics Inc (MYGN) latest cached earnings event is "MYGN earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached MYGN filing is 8-K · Oct 9, 2026. Filings: https://lician.com/sec/mygn